Exchange: NASDAQ·Updated 07:30 PM EST

OCUL Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 09

Estimated EPS

-$0.36

Reported EPS

-$0.42

Surprise

-15.55%

Estimated Rev

$14.27M

Reported Rev

$12.87M

Surprise

-9.8%

• Reported GAAP EPS of -$0.42 down -10.53% YoY • Reported revenue of $12.87M down -11.49% YoY • Ocular Therapeutix believes its $530.6M cash balance is sufficient to support planned operating expenses, debt service and capital expenditures into 2028; projection excludes full manufacturing and commercial-team scaling expenses.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.43
--
--
N/A
Q3 '26
-$0.36
-$0.42
-15.55%
MISSED
Q2 '26
-$0.40
-$0.35
11.49%
BEAT
Q1 '26
-$0.31
-$0.40
-27.07%
MISSED
Q4 '25
-$0.32
-$0.29
9.62%
BEAT

Advertisement|Remove ads.